Domain Fine-Tuning FinBERT on Finnish Histopathological Reports: Train-Time Signals and Downstream Correlations

Digital healthcare generates vast amounts of clinical text that can support AI-assisted applications, yet German biomedical language models remain limited by older architectures or restricted training data. We present ChristBERT (Clinical- and Healthcare-Related Issues and Subjects Tuned BERT), a family of domain-specific German RoBERTa-based language models trained on a 13.5GB corpus of scientific publications, clinical texts, health-related web content, and translated clinical resources. To investigate the impact of domain adaptation strategies in German clinical NLP, we compare continued pre-training, training from scratch, and domain-specific vocabulary adaptation. The resulting models are evaluated on three medical named entity recognition tasks and two text classification tasks. ChristBERT consistently outperforms existing general-purpose and medical German language models on four of five benchmarks and establishes a new state of the art for German clinical language modeling. Our results show that the optimal adaptation strategy is task-dependent: in our evaluation, training from scratch is particularly effective for highly specialized clinical texts, whereas continued pre-training performs well on more commonly written medical texts. All models are publicly released to support future research and applications in German medical NLP.

This paper narrows the performance gap between small, specialized models and significantly larger general-purpose models through domain adaptation via continual pre-training and merging. We address the scarcity of specialized non-English data by constructing a high-quality German medical corpus (FineMed-de) from FineWeb2. This corpus is used to continually pre-train and merge three well-known LLMs (ranging from $7B$ to $24B$ parameters), creating the DeFineMed model family. A comprehensive evaluation confirms that specialization dramatically enhances $7B$ model performance on German medical benchmarks. Furthermore, the pairwise win-rate analysis of the Qwen2.5-based models demonstrates an approximately $3.5$-fold increase in the win-rate against the much larger Mistral-Small-24B-Instruct through domain adaptation. This evidence positions specialized $7B$ models as a competitive, resource-efficient solution for complex medical instruction-following tasks. While model merging successfully restores instruction-following abilities, a subsequent failure mode analysis reveals inherent trade-offs, including the introduction of language mixing and increased verbosity, highlighting the need for more targeted fine-tuning in future work. This research provides a robust, compliant methodology for developing specialized LLMs, serving as the foundation for practical use in German-speaking healthcare contexts.

Large Language Models such as GPT-4o and GPT-5 achieve strong zero-shot performance on biomedical claim verification, but cost and opacity limit scalable use. We fine-tune three small LLMs: Phi-3-mini (3.8B), Qwen2.5-3B, and Mistral-7B, via QLoRA on SciFact and HealthVer, providing the first study of QLoRA models against GPT-4o and fine-tuned BioLinkBERT encoders. Mistral-7B QLoRA surpasses both GPT-4o and GPT-5 (up to 12% F1 gain) at a fractional cost using just 1,008 training examples. We conduct extensive in-domain and cross-domain evaluation: models trained on SciFact tested on HealthVer and vice versa, at matched sizes to isolate dataset structure from data quantity. We identify a previously unreported structural artifact in SciFact that inflates in-domain scores, and show through bidirectional out-of-domain evaluation that training on structurally sound data enables robust cross-domain transfer. We plan to release all code and adapter checkpoints.